Unveiling the Hidden Stroke Threat in Patients with Atrial Fibrillation and Primary Hyperparathyroidism.

Atherosclerosis Atrial Fibrillation Primary Hyperparathyroidism Stroke

Journal

The American journal of cardiology
ISSN: 1879-1913
Titre abrégé: Am J Cardiol
Pays: United States
ID NLM: 0207277

Informations de publication

Date de publication:
05 Mar 2024
Historique:
received: 09 01 2024
revised: 17 02 2024
accepted: 01 03 2024
medline: 8 3 2024
pubmed: 8 3 2024
entrez: 7 3 2024
Statut: aheadofprint

Résumé

Recent ACC/AHA/ACCP/HRS guidelines suggest that patients with Atrial fibrillation (AF) at intermediate to low annual risk of ischemic stroke can benefit from consideration of factors that might modify their risk of stroke. The role of non-traditional risk factors such as primary hyperparathyroidism (PHPT) remains unexplored. In our study, we investigated the potential association between PHPT and the risk of ischemic stroke among patients with AF. Using data from the Nationwide Inpatient Sample Database, a retrospective cohort study focused on the adult population with AF and stratified them based on PHPT presence. Demographic information, comorbidities, and hospitalization details were extracted using ICD-10 codes. Propensity score matching was applied, encompassing over 20 confounding variables, including the risk factors outlined in the CHA

Identifiants

pubmed: 38452840
pii: S0002-9149(24)00170-X
doi: 10.1016/j.amjcard.2024.03.003
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no competing interests to report.

Auteurs

Georges Khattar (G)

Department of Internal Medicine, Staten Island University Hospital/Northwell Health, Staten Island, New York, USA. Electronic address: geokhattar22@gmail.com.

Samer Asmar (S)

Department of Internal Medicine, Staten Island University Hospital/Northwell Health, Staten Island, New York, USA.

Elie Bou Sanayeh (EB)

Department of Internal Medicine, Staten Island University Hospital/Northwell Health, Staten Island, New York, USA.

Praneeth Keesari (P)

Department of Internal Medicine, Staten Island University Hospital/Northwell Health, Staten Island, New York, USA.

Wissam Rahi (W)

Department of Internal Medicine, Lankeneau Medical Center, Wynnewood, Pennsylvania, USA; Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA.

Fouad Sakr (F)

Department of Internal Medicine, Staten Island University Hospital/Northwell Health, Staten Island, New York, USA.

Michel Khoury (M)

Department of Cardiology, Staten Island University Hospital/Northwell Health, Staten Island, New York, USA.

Michael Cinelli (M)

Department of Cardiology, Staten Island University Hospital/Northwell Health, Staten Island, New York, USA.

Samantha Lee (S)

Department of Cardiology, Staten Island University Hospital/Northwell Health, Staten Island, New York, USA.

Mitchell Weinberg (M)

Department of Interventional Cardiology and Vascular Medicine, Staten Island University Hospital/Northwell Health, Staten Island, New York, USA; Chair of Cardiology, Staten Island University Hospital/Northwell Health, Staten Island, New York, USA.

Marcin Kowalski (M)

Department of Cardiology, Staten Island University Hospital/Northwell Health, Staten Island, New York, USA; Department of Cardiac Electrophysiology, Staten Island University Hospital/Northwell Health, Staten Island, New York, USA; Assistant Professor of Cardiology, Zucker School of Medicine at Hofstra/Northwell, New York, USA.

Valay Parikh (V)

Department of Cardiology, Staten Island University Hospital/Northwell Health, Staten Island, New York, USA; Department of Cardiac Electrophysiology, Staten Island University Hospital/Northwell Health, Staten Island, New York, USA; Assistant Professor of Cardiology, Zucker School of Medicine at Hofstra/Northwell, New York, USA.

Classifications MeSH